TW230203B - - Google Patents

Info

Publication number
TW230203B
TW230203B TW082103080A TW82103080A TW230203B TW 230203 B TW230203 B TW 230203B TW 082103080 A TW082103080 A TW 082103080A TW 82103080 A TW82103080 A TW 82103080A TW 230203 B TW230203 B TW 230203B
Authority
TW
Taiwan
Prior art keywords
pct
denotes
formula
group
sec
Prior art date
Application number
TW082103080A
Other languages
English (en)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Application granted granted Critical
Publication of TW230203B publication Critical patent/TW230203B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
TW082103080A 1992-06-03 1993-04-22 TW230203B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929211779A GB9211779D0 (en) 1992-06-03 1992-06-03 Amine salts

Publications (1)

Publication Number Publication Date
TW230203B true TW230203B (zh) 1994-09-11

Family

ID=10716488

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082103080A TW230203B (zh) 1992-06-03 1993-04-22

Country Status (17)

Country Link
US (2) US5739167A (zh)
EP (1) EP0643690B1 (zh)
JP (1) JPH07507288A (zh)
KR (1) KR950701907A (zh)
AT (1) ATE166342T1 (zh)
AU (1) AU672607B2 (zh)
CA (1) CA2135394A1 (zh)
DE (1) DE69318711T2 (zh)
DK (1) DK0643690T3 (zh)
ES (1) ES2117132T3 (zh)
FI (1) FI945654A (zh)
GB (1) GB9211779D0 (zh)
HK (1) HK1009330A1 (zh)
NO (1) NO302749B1 (zh)
NZ (1) NZ252738A (zh)
TW (1) TW230203B (zh)
WO (1) WO1993024451A1 (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE27799A1 (es) * 1996-12-10 1999-03-18 Novartis Ag Formulaciones y formas polimorficas de desferrioxamina y su preparacion
US7045531B1 (en) 1997-03-11 2006-05-16 The General Hospital Corporation Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator
GB9727224D0 (en) * 1997-12-23 1998-02-25 Nycomed Imaging As Method
US6323218B1 (en) 1998-03-11 2001-11-27 The General Hospital Corporation Agents for use in the treatment of Alzheimer's disease
US6638711B1 (en) 1999-04-29 2003-10-28 The General Hospital Corporation Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation
GB0117645D0 (en) 2001-07-19 2001-09-12 Isis Innovation Therapeutic stratergies for prevention and treatment of alzheimers disease
US6958161B2 (en) * 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
US8614204B2 (en) 2003-06-06 2013-12-24 Fibrogen, Inc. Enhanced erythropoiesis and iron metabolism
US8236783B2 (en) * 2006-08-15 2012-08-07 Duke University ROS-sensitive iron chelators and methods of using the same
US9139456B2 (en) 2008-04-16 2015-09-22 The Curators Of The University Of Missouri Chelating compounds and immobilized tethered chelators
US9259670B2 (en) 2008-04-16 2016-02-16 The University Of Kentucky Research Foundation Flow-through filter to remove aluminum from medical solutions
US7932326B2 (en) * 2008-04-16 2011-04-26 The University Of Kentucky Research Foundation Chelating compounds and immobilized tethered chelators

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH438351A (de) * 1959-09-25 1967-06-30 Ciba Geigy Verfahren zur Herstellung neuer Wuchsstoffe
FR1898M (fr) * 1961-04-07 1963-07-08 Ciba Geigy Nouvelle substance utilisable en thérapeutique.
US3679660A (en) * 1969-06-09 1972-07-25 Agatha C Magnus Glucosamine-alkylsulfonate and process
US3652411A (en) * 1969-12-04 1972-03-28 Mobil Oil Corp Polyglycol base lubricant
US4419365A (en) * 1981-12-21 1983-12-06 Ciba-Geigy Corporation Method of treating Alzheimer's disease
US4684482A (en) * 1984-01-26 1987-08-04 Oral-D (L.P.) Orally effective ion chelators
IT1173992B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente idonei per uso farmaceutico orale
MX12394A (es) * 1987-07-23 1993-12-01 Ciba Geigy Ag Procedimiento par la obtencion de carbamatos de polietilenglicol.
WO1992020227A1 (en) * 1991-05-13 1992-11-26 Oral-D Substituted orally effective ion chelators related to deferoxamine

Also Published As

Publication number Publication date
NO944617D0 (no) 1994-12-01
AU4270093A (en) 1993-12-30
DE69318711D1 (de) 1998-06-25
JPH07507288A (ja) 1995-08-10
ATE166342T1 (de) 1998-06-15
US5663201A (en) 1997-09-02
ES2117132T3 (es) 1998-08-01
CA2135394A1 (en) 1993-12-09
EP0643690A1 (en) 1995-03-22
US5739167A (en) 1998-04-14
AU672607B2 (en) 1996-10-10
KR950701907A (ko) 1995-05-17
DE69318711T2 (de) 1998-11-19
HK1009330A1 (en) 1999-05-28
FI945654A0 (fi) 1994-11-30
NZ252738A (en) 1996-08-27
FI945654A (fi) 1994-11-30
EP0643690B1 (en) 1998-05-20
NO302749B1 (no) 1998-04-20
GB9211779D0 (en) 1992-07-15
WO1993024451A1 (en) 1993-12-09
DK0643690T3 (da) 1999-01-25
NO944617L (no) 1995-01-05

Similar Documents

Publication Publication Date Title
HU9501934D0 (en) Risperidone pamoate
HU9501531D0 (en) Nitric esters having a pharmacological activity and process for their preparation
CA2011294A1 (en) Carbonylation catalyst system
EP1097939A3 (en) Method for the synthesis of isoguanosine and its 2'-derivatives
EP0687684A4 (en) COMPOUND ASSOCIATED WITH LEWIS SYSTEM, PROCESS FOR OBTAINING THIS COMPOUND AND ANTI-INFLAMMATORY
TW230203B (zh)
GR3024297T3 (en) Intermediate for azithromycin
GR3023938T3 (en) 3',5'-ditertbutyl-4'-hydroxyflavones, method for their preparation and pharmaceutical compositions with an antioxidant and antivasoconstricting activity
GR1002573B (el) Μικροβιακη μεθοδος παρασκευης μεβινολινης.
TW252971B (zh)
TW278071B (zh)
MY103393A (en) 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents and preparation thereof
ATE163414T1 (de) Verfahren zur herstellung von triazolonderivaten
MY103910A (en) 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents and preparation thereof
CA2146322A1 (en) Oleaginous compositions
HUT51258A (en) Process for producing five-member nitrogenous heteroaromatic compounds
AU3604093A (en) Use of 5,5'-dithio-bis(2-nitrobenzoic acid) for inhibition of HIV protease
TW239124B (en) Process for the preparation of 2,4,5-tribromopyrrole-3-carbonitrile
EP0196330A1 (de) Verwendung von pyrrothinderivaten.
AU2859792A (en) 5,6-dihydro-dibenz(b,e)azepine-6,11-dione-11-oximes
HRP940174B1 (en) A chemical process for a synthesis of an antibacterial agent with an intermediate
PL311582A1 (en) Method of obtaining n,g-monoalkyl-l-arginin and affinite compounds